Ami Organics Limited (BOM:543349)

Market Cap	99.91B
Revenue (ttm)	9.23B
Net Income (ttm)	1.21B
Shares Out	n/a
EPS (ttm)	26.82
PE Ratio	82.31
Forward PE	n/a
Dividend	3.00 (0.13%)
Ex-Dividend Date	n/a

Volume	9,386
Average Volume	15,039
Open	2,381.55
Previous Close	2,381.60
Day's Range	2,358.60 - 2,447.15
52-Week Range	1,014.45 - 2,643.50
Beta	n/a
RSI	57.61
Earnings Date	May 30, 2025

About Ami Organics

Ami Organics Limited engages in the research and development, manufacture, and sale of pharmaceutical intermediates in India and internationally. The company offers pharma intermediates for use in regulated and generic active pharmaceutical ingredients for anti-retroviral, anti-inflammatory, anti-psychotic, anti-cancer, anti-Parkinson’s, antidepressant, and anticoagulant applications, as well as in new chemical entities. It also provides specialty chemicals for use in agrochemicals, cosmetics, and polymers; and parabens and parabens formulation...

• Industry: Medicinal Chemicals and Botanical Products
• Founded: 2004
• Employees: 676
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 543349

Financial Performance

In 2023, Ami Organics's revenue was 7.17 billion, an increase of 16.33% compared to the previous year's 6.17 billion. Earnings were 427.73 million, a decrease of -48.65%.